Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis
Carlos Fernández(Universidad de Salamanca), M J Berruezo, David Gallardo(Instituto Nacional de Cancerología), Carlos Salvador‐Osuna(Hospital Universitario Miguel Servet), A. Asensio(Hospital General San Jorge), Maria Cláudia Santos‐Silva(Universidade Federal de Santa Catarina), A M Palomo-Hernández(Hospital Xeral Calde), María Jara‐Acevedo(Instituto de Investigación Biomédica de Salamanca), María Laura Gutiérrez(Universidad de Salamanca), Enrique Colado(Hospital Universitario Central de Asturias), Juana Ciudad(Universidad de Salamanca), José Ángel Díaz Arias(Complejo Hospitalario Universitario de Santiago), Carlos Cerveró(Hospital Virgen de la Luz), Raquel Saldaña(Hospital Jerez Puerta del Sur), Sergio Matarraz(Universidad de Salamanca), Antonio López, Nicolás González(Hospital Obispo Polanco), María Luz Sánchez(Universidad de Salamanca), Oliver Gutiérrez(Hospital Universitario Río Hortega), Ana Carbone-Bañeres(Hospital Universitario Miguel Servet), Ricarda García‐Sánchez(Hospital Clínico Universitario Virgen de la Victoria)
Cited by 13
Related Papers
Non-coding recurrent mutations in chronic lymphocytic leukaemia
|Nature|2015|851
Risk factors and outcome of COVID-19 in patients with hematological malignancies
|Experimental Hematology and Oncology|2020|159
Nanoparticles Made From Xyloglucan-Block-Polycaprolactone Copolymers: Safety Assessment for Drug Delivery
|Toxicological Sciences|2015|102
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group
|Haematologica|2016|100
Ester derivatives of gallic acid with potential toxicity toward L1210 leukemia cells
|Bioorganic & Medicinal Chemistry|2008|93